Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
29 studies found for:    " June 30, 2010":" July 30, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" June 30, 2010":" July 30, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Withdrawn A Pilot Study to Determine if Raltegravir Eradicates HIV From Peripheral Blood Mononuclear Cells
Conditions: HIV Infections;   Acquired Immune Deficiency Syndrome
Interventions: Drug: Raltegravir plus Truvada;   Drug: Atripla
2 Active, not recruiting Peer Leaders as HIV Risk Reduction Change Agents Among Injection Drug Users (IDUs) in Ukraine
Conditions: HIV Infection;   HIV Risk Behaviors
Interventions: Behavioral: Peer Education Model;   Behavioral: HIV Counseling and Education Model
3 Completed Impact of Nutrition Intervention on HIV/AIDS Infected Patients
Conditions: Human Immunodeficiency Virus (HIV);   Acquired Immune Deficiency Syndrome (AIDS)
Interventions: Dietary Supplement: Theragran-M; Ensure Plus;   Dietary Supplement: Theragran-M
4 Recruiting Reduction of Drug Use and HIV Risk Among Out-of-Treatment Methamphetamine Users
Condition: HIV Infections
Interventions: Behavioral: HIV Testing and Counseling;   Behavioral: Contingency Management;   Behavioral: Strengths-based case management
5 Active, not recruiting Home Self-Testing for HIV to Increase HIV Testing Frequency in Men Who Have Sex With Men (The iTest Study)
Condition: HIV
Interventions: Behavioral: Home HIV self-testing with OraQuick ADVANCE® Rapid HIV-1/2 Antibody Test;   Device: Home HIV self-testing with OraQuick ADVANCE® Rapid HIV-1/2 Antibody Test
6 Active, not recruiting Antigenic Competition in HIV Preventive Vaccines
Condition: HIV Infections
Interventions: Biological: rAd5 Gag-Pol Env A/B/C;   Biological: rAd5 Gag-Pol
7 Recruiting The Use of Leukapheresis to Support HIV Pathogenesis Studies
Condition: HIV
Intervention: Procedure: Leukapheresis
8 Unknown  Chronic HIV Infection and Aging in NeuroAIDS (CHAIN)
Conditions: HIV;   Aging
Intervention: Other: Observational
9 Withdrawn A Semi-Factorial Cluster-Randomized Trial to Estimate the Effect Size of Community Mobilization and VCT Vans on the Adoption of Voluntary Counseling and Testing (VCT) Services in Andhra Pradesh, India: THE MCVCT STUDY
Conditions: HIV;   AIDS;   Epidemiology;   Prevention
Intervention:
10 Completed Behavioral Activation/Armodafinil to Treat Fatigue in HIV/AIDS
Conditions: HIV+;   Fatigue;   Goals
Interventions: Behavioral: Behavioral Activation Therapy;   Behavioral: Supportive Counseling
11 Unknown  The Study of the Prevalence of Helicobacter Pylori Infection Among HIV/AIDS Cohort
Condition: HIV
Intervention:
12 Completed Computer-Assisted Tailored Cue-card Health [CATCH] Study
Conditions: Human Immunodeficiency Virus;   STDs;   Hepatitis, Viral, Human
Intervention: Behavioral: Tailored Cue Cards
13 Terminated Intrauterine Insemination In HIV-Discordant Couples
Conditions: HIV-1;   Fertility;   Infertility
Intervention: Other: Sperm Washing with Intrauterine Insemination (IUI)
14 Unknown  Study of Cell Phone SMS Messages for Prevention of Maternal to Child Transmission of HIV
Condition: HIV Infections
Intervention: Behavioral: cell phone sms text messaging
15 Unknown  Pilot Study of Raltegravir Lipodystrophy IISP
Condition: HIV Infection
Intervention: Drug: Raltegravir
16 Recruiting Auto-immunity and Pulmonary Arterial Hypertension
Conditions: Pulmonary Arterial Hypertension;   HIV Infection;   Congenital Heart Defect;   Systemic Sclerosis;   Connective Tissue Disease
Interventions: Procedure: skin biopsy;   Other: Blood Sample
17 Active, not recruiting A Safety and Immunogenicity Study of a Plasmid DNA Prime and MVA Boost Vaccine in HIV-1 (Human Immunodeficiency Virus-1) Infected Adults on ART
Condition: HIV-1 Infection
Intervention: Biological: JS7 plasmid DNA and MVA62B vaccine
18 Unknown  Impact of Raltegravir on HIV-1 cDNA Slope Following Antiretroviral Therapy (ART) Initiation
Condition: HIV-1
Intervention:
19 Completed A Phase II/III Trial of Lopinavir/Ritonavir Dosed According to the WHO Pediatric Weight Band Dosing Guidelines
Condition: HIV
Intervention: Drug: Lopinavir/ritonavir
20 Active, not recruiting RETRIeVE: ReversE TranscRiptase Inhibitor hiV Practice
Condition: HIV Positive
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-29) Show next page of results    Last Page
Indicates status has not been verified in more than two years